|
MechanismBcl-2 inhibitors |
Active Org.- |
|
Active Indication- |
|
Drug Highest PhasePending |
First Approval Ctry. / Loc.- |
First Approval Date- |
100 Clinical Results associated with Fuzhou Jinshan Institute of Biomedicine
0 Patents (Medical) associated with Fuzhou Jinshan Institute of Biomedicine
100 Deals associated with Fuzhou Jinshan Institute of Biomedicine
100 Translational Medicine associated with Fuzhou Jinshan Institute of Biomedicine